Cite
APA Citation
Chen‐Liang, T., Casado‐Prieto, A. M., Campos‐Rodríguez, V., Hurtado, A. M., Amigo, M. L., García‐Malo, M. D., Vicente, V., Ortuño, F. J., & Jerez, A. (n.d.). an increased percentage of myeloid CD34+ bone marrow cells stratifies intermediate IPSS‐R myelodysplastic syndrome patients into prognostically significant groups. International journal of laboratory hematology, 40, 549–555. http://access.bl.uk/ark:/81055/vdc_100068807315.0x000012